The emergence and global proliferation of SARS-CoV-2 has required the rapid development of high quality in vitro diagnostics. Not only are diagnostics needed for disease- and immune-status diagnosis, but play an important role in the development of effective countermeasures. Central to the performance of any high quality serological diagnostic is the selection, development and application of high quality biological reagents.
Download this eBook to learn more about:
Technology Networks Limited
Woodview | Bull Lane Industrial Estate | Sudbury | C010 0FD | UK
Email: privacy@technologynetworks.com
© 2020 Technology Networks. All rights reserved
Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy